Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2336-2342
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 190
The WHO has declared the end of pandemic phase of COVID‐19: Way to come back in the normal life
Rapty Sarker, A. S. M. Roknuzzaman, Nazmunnahar Nazmunnahar, et al.
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 46
Omicron variant: Current insights and future directions
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 66
SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic
Ranjan K. Mohapatra, Satwik Kuppili, Tarun Kumar Suvvari, et al.
Chemical Biology & Drug Design (2022) Vol. 99, Iss. 5, pp. 769-788
Open Access | Times Cited: 58
Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, et al.
International Journal of Biological Macromolecules (2022) Vol. 219, pp. 980-997
Open Access | Times Cited: 52
Challenges of the Omicron (B.1.1.529) Variant and Its Lineages: A Global Perspective
Ranjan K. Mohapatra, Venkataramana Kandi, Sarika Verma, et al.
ChemBioChem (2022) Vol. 23, Iss. 9
Open Access | Times Cited: 51
The recombinant variants of SARS‐CoV‐2: Concerns continues amid COVID‐19 pandemic
Ranjan K. Mohapatra, Venkataramana Kandi, Hardeep Singh Tuli, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3506-3508
Open Access | Times Cited: 46
Indiscriminate Use of Antibiotics for COVID-19 Treatment in South Asian Countries is a Threat for Future Pandemics Due to Antibiotic Resistance
Sohel Daria, Md. Rabiul Islam
Clinical Pathology (2022) Vol. 15
Open Access | Times Cited: 42
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis
Mahsa Bazargan, Reza Elahi, Abdolreza Esmaeilzadeh
The Journal of Gene Medicine (2022) Vol. 24, Iss. 7
Open Access | Times Cited: 42
Omicron – The new SARS‐CoV‐2 challenge?
Alexandra Lino, Marita A. Cardoso, Paula Martins‐Lopes, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 4
Open Access | Times Cited: 39
Comparative evaluation of authorized drugs for treating Covid‐19 patients
Towhidul Islam, Moynul Hasan, Mohammad Saydur Rahman, et al.
Health Science Reports (2022) Vol. 5, Iss. 4
Open Access | Times Cited: 38
Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 263-266
Open Access | Times Cited: 25
A global analysis of the effectiveness of policy responses to COVID-19
Kwadwo Agyapon-Ntra, Patrick McSharry
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Fungal bioremediation: An overview of the mechanisms, applications and future perspectives
D. Yuvaraj, R. Gnanasekaran, G. Koteswara Reddy, et al.
Environmental Chemistry and Ecotoxicology (2024) Vol. 6, pp. 293-302
Open Access | Times Cited: 13
The WHO has Declared COVID-19 is No Longer a Pandemic-Level Threat: A Perspective Evaluating Potential Public Health Impacts
A. S. M. Roknuzzaman, Rapty Sarker, Nazmunnahar Nazmunnahar, et al.
Clinical Pathology (2024) Vol. 17
Open Access | Times Cited: 8
The latest Omicron BA.4 and BA.5 lineages are frowning toward COVID‐19 preventive measures: A threat to global public health
Md. Rabiul Islam, Mohammad Shahriar, Mohiuddin Ahmed Bhuiyan
Health Science Reports (2022) Vol. 5, Iss. 6
Open Access | Times Cited: 34
Immune Response to SARS-CoV-2 Vaccines
Navya Bellamkonda, Upendra P. Lambe, Sonali Sawant, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 32
Viral load decrease in SARS‐CoV‐2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents
Valentina Mazzotta, Alessandro Cozzi Lepri, Francesca Colavita, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 27
SARS‐COV‐2 Omicron subvariant BF.7 is again triggering the Covid fear: What we need to know and what we should do?
Adnan Akif, Mohiuddin Ahmed Bhuiyan, Md. Rabiul Islam
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 19
The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review
Ranjan K. Mohapatra, Sarika Verma, Venkataramana Kandi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Open Access | Times Cited: 16
SARS-CoV-2 Omicron Spike shows strong binding affinity and favourable interaction landscape with the TLR4/MD2 compared to other variants
Chiranjib Chakraborty, Bidyut Mallick, Manojit Bhattacharya, et al.
Journal of Genetic Engineering and Biotechnology (2024) Vol. 22, Iss. 1, pp. 100347-100347
Open Access | Times Cited: 5
Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
Ailan Xu, Bixia Hong, Fuxing Lou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 25
Prevalence and associated risk factors for mental health problems among female university students during COVID-19 pandemic: A cross-sectional study findings from Dhaka, Bangladesh
Zabun Nahar, Md. Sohan, Kaniz Farzana Supti, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e10890-e10890
Open Access | Times Cited: 25
Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update
Ranjan K. Mohapatra, Nahed A. El‐Shall, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 24
The spreading of monkeypox in nonendemic countries has created panic across the world: Could it be another threat?
Md. Rabiul Islam, Md. Asaduzzaman, Mohammad Shahriar, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top